These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16053988)

  • 1. Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
    Yokoyama H; Averill DB; Brosnihan KB; Smith RD; Schiffrin EL; Ferrario CM
    Am J Hypertens; 2005 Jul; 18(7):922-9. PubMed ID: 16053988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats.
    Igase M; Strawn WB; Gallagher PE; Geary RL; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1013-9. PubMed ID: 15833808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).
    Igase M; Yokoyama H; Ferrario CM
    Ther Adv Cardiovasc Dis; 2011 Dec; 5(6):297-304. PubMed ID: 22089474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
    Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Waki H; Maeda M; Ogawa H; Kim-Mitsuyama S
    Atherosclerosis; 2014 Sep; 236(1):101-7. PubMed ID: 25016364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL; Park JB; Pu Q
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
    Igase M; Kohara K; Nagai T; Miki T; Ferrario CM
    Hypertens Res; 2008 Mar; 31(3):553-9. PubMed ID: 18497476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction.
    Asai T; Kushiro T; Fujita H; Kanmatsuse K
    Hypertens Res; 2005 Jan; 28(1):79-87. PubMed ID: 15969258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.
    Smith RD; Yokoyama H; Averill DB; Cooke L; Brosnihan KB; Schiffrin EL; Ferrario CM
    Am J Cardiovasc Drugs; 2006; 6(5):335-42. PubMed ID: 17083268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats.
    Porteri E; Rodella L; Rizzoni D; Rezzani R; Paiardi S; Sleiman I; De Ciuceis C; Boari GE; Castellano M; Bianchi R; Agabiti-Rosei E
    Blood Press; 2005; 14(3):184-92. PubMed ID: 16036499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
    Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
    Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
    Morton JJ; Beattie EC; MacPherson F
    J Vasc Res; 1992; 29(3):264-9. PubMed ID: 1387008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
    Mörtsell D; Malmqvist K; Held C; Kahan T
    J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
    Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y
    Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; López B; Edner M; González A; Díez J; Malmqvist K
    J Hypertens; 2007 Sep; 25(9):1958-66. PubMed ID: 17762662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats.
    Takai S; Jin D; Ikeda H; Sakonjo H; Miyazaki M
    Hypertens Res; 2009 Oct; 32(10):853-60. PubMed ID: 19662023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diastolic dysfunction in hypertensive left ventricular hypertrophy.
    Bella JN
    Am J Hypertens; 2006 Sep; 19(9):937-8. PubMed ID: 16942936
    [No Abstract]   [Full Text] [Related]  

  • 20. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.